Isolation and purification of antigenic components of Cryptococcus
- PMID: 19089377
- PMCID: PMC3297022
- DOI: 10.1007/978-1-59745-204-5_7
Isolation and purification of antigenic components of Cryptococcus
Abstract
The encapsulated fungal pathogens Cryptococcus neoformans and Cryptococcus gattii are significant agents of life-threatening infections, particularly in persons with suppressed cell-mediated immunity. This chapter provides detailed methodology for the purification of two of the major antigen fractions of C. neoformans: glucuronoxylomannan (GXM) and mannoprotein (MP). GXM is the primary component of the polysaccharide capsule, which is the major cryptococcal virulence factor. In contrast, MPs have been identified as key antigens that stimulate T-cell responses. Purification of GXM and MP should assist investigators studying the antigenic, biochemical, and virulence properties of Cryptococcus species.
Figures
References
-
- Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Reviews of Infectious Diseases. 1991;13:1163–1169. - PubMed
-
- Shoham S, Levitz SM. The immune response to fungal infections. British Journal of Haematology. 2005;129:569–582. - PubMed
-
- Singh N, Gayowski T, Wagener MM, Marino IR. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clinical Transplantation. 1997;11:66–70. - PubMed
-
- Kwon-Chung KJ, Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Research. 2006;6:574–587. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
